Prime Medicine Inc (PRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -153,606 | -101,088 | -45,761 | -198,133 | -132,490 |
| Depreciation Amortization | 1,462 | 774 | 640 | 1,245 | 1,086 |
| Income taxes - deferred | N/A | N/A | 134 | -279 | -279 |
| Accounts payable and accrued liabilities | -7,717 | -9,230 | -5,880 | 9,140 | 6,861 |
| Other Working Capital | -17,784 | -34,860 | -30,111 | 2,647 | -11,803 |
| Other Operating Activity | 38,535 | 31,206 | 13,271 | 19,968 | 15,077 |
| Operating Cash Flow | $-139,110 | $-113,198 | $-67,707 | $-165,412 | $-121,548 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 24,983 | -25,912 | -34,708 | 27,605 | -15,520 |
| PPE Investments | -5,503 | -4,226 | -2,324 | -8,724 | -6,884 |
| Other Investing Activity | 724 | 0 | 0 | -170 | -170 |
| Investing Cash Flow | $20,204 | $-30,138 | $-37,032 | $18,711 | $-22,574 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 189,875 | 151,362 | 151,327 | 655 | 461 |
| Other Financing Activity | 6,000 | 6,000 | 6,000 | 0 | 0 |
| Financing Cash Flow | $195,875 | $157,362 | $157,327 | $655 | $461 |
| Beginning Cash Position | 55,070 | 55,070 | 55,070 | 201,116 | 201,116 |
| End Cash Position | 132,039 | 69,096 | 107,658 | 55,070 | 57,455 |
| Net Cash Flow | $76,969 | $14,026 | $52,588 | $-146,046 | $-143,661 |
| Free Cash Flow | |||||
| Operating Cash Flow | -139,110 | -113,198 | -67,707 | -165,412 | -121,548 |
| Capital Expenditure | -5,503 | -4,226 | -2,324 | -8,724 | -6,884 |
| Free Cash Flow | -144,613 | -117,424 | -70,031 | -174,136 | -128,432 |